ETFs

ETF (UCITS compliant)

L&G Healthcare Technology & Innovation UCITS ETF

USD Accumulating ETF Class

ISINIE00BK5BC677

TER0.49%

Fund aim

The L&G Healthcare Technology & Innovation UCITS ETF (the "ETF") aims to track the performance of the ROBO Global® Healthcare Technology and Innovation Index TR (the “Index”).

Fund snapshot

  • Long-term allocation

Long-term megatrend that we believe is radically transforming the way we live and work

  • High growth potential

Aims to capture the outsized growth potential of the healthcare technology industry

  • Leveraging industry expertise

An index tracking investment strategy that is supported by a team of healthcare technology experts

  • Does it have a sustainable objective?

The Fund has a sustainable investment objective as it invests in companies which (i) contribute to social objectives, (ii) do not significantly harm any environmental or social objectives, and (iii) follow good governance practices. Further information can be found in the Fund Supplement.

Fund facts

Fund size
Base currency USD
Fund launch date 2 Jul 2019
Share class launch 2 Jul 2019
Domicile Ireland
Replication method Physical - full replication

Benchmark

ROBO Global® Healthcare Technology and Innovation Index TR

Index description

ROBO Global® Healthcare Technology and Innovation Index TR

The Index aims to track the performance of a basket of companies that are actively engaged in the healthcare technology value-chain.

The index is comprised of companies which are publicly traded on various stock exchanges around the world that have a distinct portion of their business and revenue derived from the field of healthcare technologies, and the potential to grow within this space through innovation and/or market adoption of their products and/or services. Companies are included in the index receive a "HTEC Score"  comprised of factors representing (1)the levels of revenue the company receives from innovative healthcare technologies, (2) the levels of investment the firm makes in healthcare technologies, (3) the market and technology leadership of the firm within the universe.

A company is only eligible for inclusion in the Index if it is of a sufficient size (determined by reference to the total market value of its shares) and it is sufficiently "liquid" ( a measure of how actively its shares are traded on a daily basis). Within the Index, companies are weighted according a modified HTEC-factor weighting scheme. The Index is rebalanced quarterly in March, June, September and December.

Index data

ProviderROBO Global®
Bloomberg codeHTECTR
Reuters code.HTECTR
TypeTotal Return
WebsiteGo to website

Performance

Performance for the USD Accumulating unit class in USD, launched on 02 July 2019. Source: Lipper. Performance assumes all ETF charges have been taken and that all income generated by the investments, after deduction of tax, remains in the ETF.
Past performance is not a reliable indicator of future performance. Markets could develop very differently in the future. It can help you to assess how the fund has been managed in the past. The tables and charts above shows the fund's performance as the percentage loss or gain per year over the last 10 years.
Share class launch date: 02 Jul 2019
Benchmark: ROBO Global® Healthcare Technology and Innovation Index TR
Share class launch date: 02 Jul 2019
Benchmark: ROBO Global® Healthcare Technology and Innovation Index TR

Performance scenarios

The figures shown include all the costs of the product itself, but may not include all the costs that you pay to your advisor or distributor. The figures do not take into account your personal tax situation, which may also affect how much you get back.
What you will get from this product depends on future market performance. Market developments in the future are uncertain and cannot be accurately predicted.
The unfavourable, moderate, and favourable scenarios shown are illustrations using the worst, average, and best performance of the product with input from the over the last 10 years. Markets could develop very differently in the future.

Example investment: 10,000 USD

Data for the selected period isn't currently available

Portfolio breakdown

Top 10 constituents22.6%
Rest of Index77.4%
Number of constituents in Index61

Top 10 constituents (%)

GRAIL2.8
CareDx2.4
Natera2.4
Twist Bioscience2.3
Intuitive Surgical2.2
Moderna2.1
Glaukos Corp.2.1
Thermo Fisher Scientific2.1
Guardant Health2.1
Tempus AI2.0

Sector (%)

Health Care
96.0
Consumer Staples
2.5
Information Technology
1.5

All data source LGIM unless otherwise stated. Totals may not sum to 100% due to rounding. The breakdowns shown relate to the Index. The ETF’s portfolio may deviate from the portfolio of the Index.

Loading recommendations…

Fund managers

L&G Index Fund Management Team headshot

L&G Index Fund Management Team

The skill set and expertise we have developed over 35+ years in index management has allowed us to continuously evolve our investment processes. The Index Fund Management team comprises 30 fund managers with an average experience of 15 years, supported by 33 broader team members. Management oversight is provided by Dave Barron, Global Head of Index, ETFs & Systematic Solutions. The team also has full access to the resources and research of other specialists within L&G, including economists and strategists.

SFDR categorisation

The sustainable investment objective of the Fund is to provide exposure to the global healthcare technology industry. The Fund seeks to achieve its investment objective by tracking the performance of the ROBO Global® Healthcare Technology and Innovation Index TR (the “Index”). The Index is a reference benchmark that has been designated for the purpose of attaining the sustainable investment objective of the Fund.

Literature

Prices

Pricing information

Price time16:00 EST (NY)
CurrencyUSD
Monthly price history

Download full price history

Listings and codes

Listings

ExchangeCurrencyTickerISINBloombergWKNReutersListing dateTrading hours (local)
London Stock Exchange
GBPDOCGIE00BK5BC677DOCG LNA2PM51DOCG.L02/07/201908:00 - 16:30
London Stock Exchange
USDDOCTIE00BK5BC677DOCT LNA2PM51DOCT.L02/07/201908:00 - 16:30
Borsa Italiana
EURDOCTIE00BK5BC677DOCT IMA2PM51LGDOCT.MI10/09/201909:00 - 17:30
Deutsche Börse Xetra
EURXMLHIE00BK5BC677XMLH GYA2PM51DOCT.DE10/09/201909:00 - 17:30
SIX Swiss Exchange
CHFDOCTIE00BK5BC677DOCT SWA2PM51DOCT.S05/06/202009:00 - 17:30

Share class codes

ISINIE00BK5BC677
SEDOLBKF3JJ5
BloombergDOCT
WKNA2PM51

Dealing information

IssuerLegal & General UCITS ETF Plc
Depositary and TrusteeThe Bank of New York Mellon SA/NV, Dublin Branch
Securities regulatorCentral Bank of Ireland

Country registration

This share class is registered for sale in the following countries:

Austria
Denmark
Finland
France
Germany
Ireland
Italy
Luxembourg
Netherlands
Norway
Portugal
Singapore*
Spain
Sweden
Switzerland
United Kingdom

* The Fund is on the list of restricted collective investment schemes, but is not authorised or recognised by the Monetary Authority of Singapore (the “MAS”) and the Shares cannot be offered or marketed to retail clients.